The Future of Nuclear Cardiology: Flyrcado, Artificial Intelligence, and Mobile PET Imaging
Nuclear Cardiology Is Entering a New Era Advancements in imaging technology, radiopharmaceutical development, and artificial intelligence are transforming the future of nuclear cardiology. Healthcare providers now have access to tools that improve diagnostic precision, streamline workflows, and enhance patient care. Among the most exciting developments are Flyrcado® (Flurpiridaz F-18), artificial intelligence-assisted imaging analysis, and the […]